Trials / Conditions / Chronic Myelomonocytic Leukemia-2

Chronic Myelomonocytic Leukemia-2

9 registered clinical trials studyying Chronic Myelomonocytic Leukemia-2 — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) NCT06950034	Solu Therapeutics, Inc	Phase 1
Active Not Recruiting	Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloprolifera NCT05038592	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Recruiting	Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and NCT05584761	The First Affiliated Hospital with Nanjing Medical University	Phase 1 / Phase 2
Recruiting	Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CM NCT04771572	Newave Pharmaceutical Inc	Phase 1
Active Not Recruiting	Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia NCT04734990	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grad NCT02756572	University of Washington	Phase 2
Completed	Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk My NCT02121418	University of Washington	N/A
Completed	Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia o NCT02029950	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic S NCT01522976	National Cancer Institute (NCI)	Phase 2